“A renaissance is taking place in the world of aortic valve repair.
While patients have benefited from advances in mitral valve repair procedures (long-term durability, freedom from re-operation and normal life expectancy), reproducing those results using aortic valve repair techniques has been challenging.
Unfortunately, patients with aortic valve regurgitation – also known as aortic insufficiency – had limited treatment options, including tissue and mechanical heart valve replacement devices.
In case you missed it… The HAART Aortic Annuloplasty Device received clearance from the U.S. Food & Drug Administration (FDA). This is a very important development for patients who are searching for a potential long-term fix for their leaking aortic valves. The great news is that the early operative results using the HAART device have supported a global trend toward aortic valve repair.”
Read the entire article on the HeartValveSurgery.com website.